In 2012, investigations found that researcher Yoshitaka Fujii had fabricated well in excess of 100 papers, and recommended scores of retractions. Yet years later, publishers are still cleaning the literature of his problematic work.
For anyone not familiar the Fujii case: After researchers raised concerns about Fujii’s work, an anesthesiologist used statistical tools to determine the odds the results were likely to have come from actual experiments. The answer: infinitesimally small. (For more on Fujii’s “dramatic fall from grace,” check out this in-depth Nautilus article published by our co-founders in 2015.)
Over the last several months, four journals — three published by Elsevier, one by Springer — have retracted 21 papers by Fujii. Seventeen retractions stem from one journal — Clinical Therapeutics.
Twelve of the retractions are accompanied by the following text: Continue reading What took more than five years? Elsevier retracts 20 papers by world’s most prolific fraudster

A researcher collected her own blood and forged the labels so it would appear to be samples from nearly 100 people, according to a 
A few years ago, Richard Miller of the University of Michigan had a serious dilemma: He discovered a former researcher in his lab was doing research somewhere else. Normally, that would be fine — except this research had admitted to committing misconduct in Miller’s lab.
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a
We finally have some clarity on the case of the erroneous retraction over at the 
